Working to transform disease diagnosis through comprehensive multiomic profiling.
Cutting-edge multiomic profiling
Our approach allows us to discover multiomic biomarkers from a DNA sample using a simple, single, streamlined workflow.
We use advanced bioinformatic workflows and machine learning approaches to analyse distinct multiomic patterns that drive patient specific insights and diagnosis.
OUR TECHNOLOGY
Epigenetic Markers
Our multiomic platform incorporates an innovative approach to epigenetic analysis. At its heart is a groundbreaking chemoenzymatic method that sorts hypomethylated and hypermethylated biomolecules, providing access to epigenetic biomarkers associated with diseases. In the context of cancer, these markers play a crucial role in enabling earlier diagnosis and pinpointing the tumours tissue of origin.
OUR TECHNOLOGY
Genomic Markers
Our multiomic platform allows for seamless integration of gene panels or whole genome sequencing. We leverage this feature to analyse key disease-driving mutations and genomic alterations.
OUR TECHNOLOGY
Fragmentomic Markers
Our advanced bioinformatic algorithms grant access to DNA fragmentomic patterns. These markers encompass the length, distribution, and end characteristics of DNA fragments. This offers valuable insights into disease status as fragmentomic features can serve as biomarkers for early disease diagnosis and the identification of tissue of origin.
Contact Us.
For more information, please feel free to get in touch by completing the enquiry form. We aim to respond to all enquiries within 24 hours.
OUR TECHNOLOGY
Working to transform disease diagnosis through comprehensive multiomic profiling.
Our approach allows us to discover multiomic biomarkers from a DNA sample using a simple, single, streamlined workflow.
We use advanced bioinformatic workflows and machine learning approaches to analyse distinct multiomic patterns that drive patient specific insights and diagnosis.
OUR TECHNOLOGY
Epigenetic Markers
Our multiomic platform incorporates an innovative approach to epigenetic analysis. At its heart is a groundbreaking chemoenzymatic method that sorts hypomethylated and hypermethylated biomolecules, providing access to epigenetic biomarkers associated with diseases. In the context of cancer, these markers play a crucial role in enabling earlier diagnosis and pinpointing the tumours tissue of origin.
OUR TECHNOLOGY
Genomic Markers
Our multiomic platform allows for seamless integration of gene panels or whole genome sequencing. We leverage this feature to analyse key disease-driving mutations and genomic alterations.
OUR TECHNOLOGY
Fragmentomic Markers
Our advanced bioinformatic algorithms grant access to DNA fragmentomic patterns. These markers encompass the length, distribution, and end characteristics of DNA fragments. This offers valuable insights into disease status as fragmentomic features can serve as biomarkers for early disease diagnosis and the identification of tissue of origin.
Contact Us.
For more information, please feel free to get in touch by completing the enquiry form. We aim to respond to all enquiries within 24 hours.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance your experience.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.